Today: 27 April 2026
Sandisk Stock Hits Record As AI Memory Bets Put Earnings In Crosshairs

Sandisk Stock Hits Record As AI Memory Bets Put Earnings In Crosshairs

Milpitas, California, April 27, 2026, 11:06 (PDT)

  • Sandisk jumped 7.4% to $1,063.55 on Monday, trading close to 9.6 million shares.
  • Melius Research kicked off its coverage with a Buy and a $1,350 target for two years out, joining a wave of bullish calls from Wall Street.
  • Sandisk Corporation is set to post its fiscal third-quarter numbers on April 30. Options traders are positioning for significant volatility.

Sandisk Corp surged to an all-time high Monday, jumping 7.4% to $1,063.55. Analysts are upping their forecasts, convinced that the AI-driven appetite for data storage is set to propel the flash-memory giant further. The move pushed Sandisk’s market cap to roughly $165.9 billion ahead of this week’s earnings report.

Timing could be key here. Sandisk is set for its fiscal third-quarter earnings call this Thursday at 1:30 p.m. Pacific, a moment that’s likely to gauge if the current NAND flash-memory rally has legs left. NAND, a chip technology that retains data even after power is lost, underpins solid-state drives and similar devices.

Sandisk shares surged after the company in January projected third-quarter revenue between $4.40 billion and $4.80 billion, with non-GAAP diluted earnings coming in at $12 to $14 per share. In the same report, Sandisk posted a 31% sequential jump in second-quarter revenue to $3.03 billion. Data-center revenue climbed 64%, thanks in large part to strong demand from AI infrastructure builders and major tech customers.

Ben Reitzes at Melius kicked off coverage on Sandisk and Micron Technology with Buy calls, assigning a $1,350 price target for Sandisk over two years and $700 for Micron. In his note, Reitzes pointed to what he called an “AI memory cycle” that could run through the decade’s end, highlighting robust demand for high-bandwidth memory, DRAM, and NAND. Investing.com

Cantor Fitzgerald bumped its Sandisk price target to $1,400 from $1,000, sticking with its Overweight call as it pointed to strong demand spanning hyperscale cloud, consumer, and client devices. Morgan Stanley also upped its target, now at $1,100, according to Investing.com.

The move dragged other names along, too. Micron jumped 4.9% Monday, according to market data. Western Digital, which spun off Sandisk as a public company in February 2025, edged down 0.4%. The company is still seen as a bellwether for the storage cycle.

Sandisk has also gotten a boost from index-driven buying. Nasdaq announced earlier this month that Sandisk is set to be added to the Nasdaq-100 Index before trading begins on April 20, taking the spot from Atlassian. The index comprises 100 of the largest non-financial stocks listed on Nasdaq and serves as the basis for more than 200 investment products managing over $600 billion.

Even so, there’s no shortage of traders piling in—and the risk is anything but minor. Options were pricing in a 16.57% implied swing for Sandisk following its earnings, signaling expectations for big action in just one session. Among mega-caps tracked by Benzinga this week, that was the highest implied move.

The big worry: memory’s cycles haven’t gone away. Should supply start ramping up ahead of forecasts—or if AI-driven data-center budgets pull back—the current pricing strength could fade, leaving those upbeat earnings projections exposed. In its January update, Sandisk pointed straight to product mix, enterprise SSD rollouts, and a demand picture that can turn fast when memory markets heat up.

Stock Market Today

  • ImmunityBio's Anktiva Sets Sales Baseline Ahead of Key 2026 Bladder Cancer Trial
    April 27, 2026, 2:25 PM EDT. ImmunityBio's (IBRX) Anktiva, approved in April 2024 for bladder cancer, drives the company's commercial momentum. The drug generated $113 million in product revenue in 2025, surging from $14.7 million in 2024. Quarterly sales accelerated 20% sequentially in Q4 2025, signaling strong physician adoption with repeat prescribing. A permanent J-code in 2025 eased reimbursement, facilitating broader U.S. uptake. Looking ahead, ImmunityBio aims to expand Anktiva's use earlier in bladder cancer treatment by targeting additional non-muscle invasive bladder cancer (NMIBC) populations. The pivotal QUILT-2.005 trial, comparing Anktiva plus BCG to BCG alone in BCG-naïve NMIBC patients, will be critical in 2026 to potentially enlarge the eligible patient base and grow sales further.

Latest article

Sandisk Stock Hits Record As AI Memory Bets Put Earnings In Crosshairs

Sandisk Stock Hits Record As AI Memory Bets Put Earnings In Crosshairs

27 April 2026
Sandisk shares jumped 7.4% to a record $1,063.55 Monday after Melius Research initiated coverage with a Buy rating and $1,350 target. Trading volume reached nearly 9.6 million shares. The company reports fiscal third-quarter results April 30, with options markets pricing in a 16.57% implied move. Sandisk joined the Nasdaq-100 Index on April 20.
Nokia Oyj Stock’s AI Run Gets Fresh Wall Street Jolt as Targets Rise

Nokia Oyj Stock’s AI Run Gets Fresh Wall Street Jolt as Targets Rise

27 April 2026
Nokia shares closed up 3.69% in Helsinki at 9.276 euros after analyst upgrades and strong first-quarter results, with U.S. shares rising 2.6%. The company reported a 54% jump in comparable operating profit to 281 million euros and a 49% increase in sales to AI and cloud customers. Nokia raised its 2026 Network Infrastructure sales growth target to 12%-14%. The first dividend instalment went ex-dividend Monday at 0.04 euros per share.
Domino’s Pizza Stock Sinks 10% After Weak Sales Outlook Signals a Tougher Value Fight

Domino’s Pizza Stock Sinks 10% After Weak Sales Outlook Signals a Tougher Value Fight

27 April 2026
Domino’s Pizza shares fell nearly 10% after the company cut its 2026 comparable-sales outlook, citing weak demand and tougher competition. U.S. same-store sales rose 0.9% in the first quarter, missing estimates, while international same-store sales slipped 0.4%. Revenue increased 3.5% to $1.15 billion, but net income dropped 6.6% to $139.8 million. The board approved another $1 billion in share buybacks.
Nokia Oyj Stock’s AI Run Gets Fresh Wall Street Jolt as Targets Rise
Previous Story

Nokia Oyj Stock’s AI Run Gets Fresh Wall Street Jolt as Targets Rise

Go toTop